Your browser doesn't support javascript.
loading
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141.
Kiyota, Naomi; Hasegawa, Yasuhisa; Takahashi, Shunji; Yokota, Tomoya; Yen, Chia-Jui; Iwae, Shigemichi; Shimizu, Yasushi; Hong, Ruey-Long; Goto, Masahiro; Kang, Jin-Hyoung; Sum Kenneth Li, Wing; Ferris, Robert L; Gillison, Maura; Namba, Yoshinobu; Monga, Manish; Lynch, Mark; Tahara, Makoto.
Afiliação
  • Kiyota N; Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan; Kobe University Hospital Cancer Center, Kobe, Japan. Electronic address: nkiyota@med.kobe-u.ac.jp.
  • Hasegawa Y; Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Nagoya, Japan. Electronic address: hasegawa@aichi-cc.jp.
  • Takahashi S; Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: s.takahashi-chemotherapy@jfcr.or.jp.
  • Yokota T; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan. Electronic address: t.yokota@scchr.jp.
  • Yen CJ; National Cheng Kung University Hospital, Tainan, Taiwan. Electronic address: yencj@mail.ncku.edu.tw.
  • Iwae S; Department of Head and Neck Surgery, Hyogo Cancer Center, Akashi, Japan. Electronic address: s.iwae@hp.pref.hyogo.jp.
  • Shimizu Y; Department of Medical Oncology, Hokkaido University Hospital, Sapporo, Japan. Electronic address: y-simz@med.hokudai.ac.jp.
  • Hong RL; National Taiwan University Hospital, Taipei, Taiwan. Electronic address: rlhong@ntu.edu.tw.
  • Goto M; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan. Electronic address: in2030@osaka-med.ac.jp.
  • Kang JH; The Catholic University Of Korea, Seoul St. Mary's Hospital, Seoul, Republic of Korea. Electronic address: oncologykang@naver.com.
  • Sum Kenneth Li W; Queen Elizabeth Hospital, Hong Kong, China. Electronic address: lws466@ha.org.hk.
  • Ferris RL; University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. Electronic address: ferrisrl@upmc.edu.
  • Gillison M; The Ohio State University, Columbus, OH, USA. Electronic address: maura.gillison@osumc.edu.
  • Namba Y; ONO Pharmaceutical Co., Ltd., Osaka, Japan. Electronic address: y.nanba@ono.co.jp.
  • Monga M; Bristol-Myers Squibb, Princeton, NJ, USA. Electronic address: Manish.Monga@bms.com.
  • Lynch M; Bristol-Myers Squibb, Princeton, NJ, USA. Electronic address: Mark.Lynch@bms.com.
  • Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan. Electronic address: matahara@east.ncc.go.jp.
Oral Oncol ; 73: 138-146, 2017 10.
Article em En | MEDLINE | ID: mdl-28939066
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço / Anticorpos Monoclonais / Recidiva Local de Neoplasia / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço / Anticorpos Monoclonais / Recidiva Local de Neoplasia / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article